Skip to content
10-Q

Quarterly Report

Sunshine Biopharma Inc. SBFM SBFMW

0001683168-25-005981

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 4.56M sh
Shares Diluted Q2 2025 · Jun 30, 2025 3.6M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $0
Stock Repurchased Q2 2025 · Jun 30, 2024 $3.14M
Capex Q2 2025 · Jun 30, 2025 $167.49K
Capex Q2 2025 · Jun 30, 2024 $1.04M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$2.99M
Stockholders Equity Q2 2025 · Jun 30, 2025 $25.68M
Stockholders Equity Q2 2025 · Mar 31, 2025 $22.7M
Stockholders Equity Q2 2025 · Dec 31, 2024 $23.5M
Current Liabilities Q2 2025 · Jun 30, 2025 $5.57M
Current Liabilities Q2 2025 · Dec 31, 2024 $6.31M
Total Liabilities Q2 2025 · Jun 30, 2025 $6.28M
Total Liabilities Q2 2025 · Dec 31, 2024 $7.06M
Current Assets Q2 2025 · Jun 30, 2025 $27.85M
Current Assets Q2 2025 · Dec 31, 2024 $25.97M
Total Assets Q2 2025 · Jun 30, 2025 $31.97M
Total Assets Q2 2025 · Dec 31, 2024 $30.56M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.82
Eps Diluted Q2 2025 · Jun 30, 2024 −$43.48
Eps Basic Q2 2025 · Jun 30, 2025 −$0.39
Eps Basic Q2 2025 · Jun 30, 2025 −$0.82
Sga Expense Q2 2025 · Jun 30, 2025 $5.48M
Sga Expense Q2 2025 · Jun 30, 2025 $9.5M
Rd Expense Q2 2025 · Jun 30, 2025 $196.23K
Rd Expense Q2 2025 · Jun 30, 2025 $411.51K
Net Income Q2 2025 · Jun 30, 2025 −$1.77M
Net Income Q2 2025 · Jun 30, 2025 −$2.95M
Operating Income Q2 2025 · Jun 30, 2025 −$2.05M
Operating Income Q2 2025 · Jun 30, 2025 −$3.35M
Gross Profit Q2 2025 · Jun 30, 2025 $3.42M
Gross Profit Q2 2025 · Jun 30, 2025 $6.15M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $5.99M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $12.16M
Revenue Q2 2025 · Jun 30, 2025 $9.41M
Revenue Q2 2025 · Jun 30, 2025 $18.31M